anemia, neutropenia, and skeletal demineralization.
Copper deficiency in patients on long-term total parenteral nutrition (TPN) is also well documented (4) (5) (6) .'
Clinical manifestations such as leukopenia., neutropema, and hypochromic anemia unresponsive to iron supplementation appear only after several months in adult patients on TPN to which copper has not been added (4);
serum copper and ceruloplasmin concentrations decline progressively in patients on unsupplemented
TPN (7, 8).
There is substantial evidence (9) that subclinical copper deficiency affects all stages of atherosclerosis and contributes to an increased risk of coronary heart disease. This concept is supported by both epidemiologic (10) and experimental studies. Abnormal electrocardiograms, hyperlipidemia, and blood pressure changes have been observed in both humans (11, 12) and animals (13) experimentally depleted of copper; cardiac lesions and hypertrophy are consistent consequences of severe copper deficiency in animals (14) . Low copper status also has been implicated as a risk factor in postmenopausal bone loss (15) . Much of the pathology of copper deficiency may be traced to metabolic defects involving various coppercontaining enzymes. (44) , and chronic hepatitis (45) . The enzymatic activity of ceruloplasmin has been found to be depressed in some men and women fed diets low in copper (23, 46) ; the activity returned to normal when copper was supplied to the diet. However, immunoreactive ceruloplasmin was not affected in these studies ( 
23, 46). It is likely that a copper-free apoceruloplasmin or an inactive form of ceruloplasmin with a reduced number of copper atoms was present during the copper deprivation (46, 47). Recent studies have indicated that the specific enzymatic activity (the ratio of enzyme activity to immunoreactive protein, ENZ/RID Cp) may be a better indicator of copper status than either the enzyme activity or immunoreactive protein alone (21). ENZ/RID Cp is sensitive to copper status (46) and is inversely related to autonomic blood pressure response during copper deprivation in young women (12). It is not influenced by nondietary factors such as gender or hormone use (21).
Serum ceruloplasmin concentration has been determined by measuring its oxidase activity (48, 49) and by nephelometry (50), radial immunodiffusion (51) , or immunoelectrophoresis techniques (44) . Measurement of the oxidase activity with p-phenylenediamine may be subject to interferences by certain anions and the oxidation product of p-phenylenediamine (52) . Discrepancies have been noted between radial immunodiffusion and various nephelometric assays (50). These discrepancies could be related to different sources of antibodies used in the assays (50 diet (11, 23) .
In contrast to serum concentrations of copper or ceruloplasmin, erythrocyte Cu-Zn-SOD activity does not seem to be affected by age, gender, or hormone use (21, 28, 58). Recent studies, however, have suggested that some conditions that produce an oxidative stress tend to increase Cu-Zn-SOD activity, even during periods of low copper intake (59, 60). Lukaski et al. (61) showed that erythrocyte Cu-Zn-SOD activity is elevated in competitive swimmers during training. It was hypothesized that this elevation was a functional adaptation to increased oxygen utilization during increased aerobic physical training.
Most available assays for Cu-Zn-SOD activity are based on the indirect measurement of activity (34) . This type of assay consists of a superoxide-generating system and a superoxide indicator that is measured spectrophotometrically. Addition of Cu-Zn-SOD inhibits the absorption change of the indicator in a degree proportional to the amount of the enzyme present.
Floh#{233} and Otting (62) and Beyer and Fridovich
(63) list several indirect assays of Cu-Zn-SOD activity; no single method seems to be favored, but methods based on the reduction of cytochrome c or on the reduction of mtroblue tetrazolium are widely used. Many of these assays are prone to interferences (64) 
